Cargando…

Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005–2014

INTRODUCTION: The aim of this study is to describe the disease burden and costs of herpes zoster (HZ) in the general adult Japanese population or patients with immunocompromised (IC) conditions or chronic disorders. METHODS: A retrospective cohort study of individuals aged 18–74 years was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imafuku, Shinichi, Matsuki, Taizo, Mizukami, Akiko, Goto, Yasushi, de Souza, Sabrina, Jégou, Céline, Bianco, Veronique, Rosillon, Dominique, Ito, Chie, Curran, Desmond, Holl, Katsiaryna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380970/ https://www.ncbi.nlm.nih.gov/pubmed/30456446 http://dx.doi.org/10.1007/s13555-018-0268-8

Ejemplares similares

Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study
por: Mizukami, Akiko, et al.
Publicado: (2017)

The Potential Public Health Impact of Herpes Zoster Vaccination of People Aged ≥ 50 Years in Japan: Results of a Markov Model Analysis
por: Watanabe, Daisuke, et al.
Publicado: (2018)

Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan
por: Nakamura, Hiroyuki, et al.
Publicado: (2017)

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
por: Teng, Lida, et al.
Publicado: (2022)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
por: Curran, Desmond, et al.
Publicado: (2023)

Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis
por: Curran, Desmond, et al.
Publicado: (2019)

Multidermatomal Herpes Zoster in immunocompromised patient
por: Park, Keon Woo, et al.
Publicado: (2020)

Healthy ageing: Herpes zoster infection and the role of zoster vaccination
por: Curran, Desmond, et al.
Publicado: (2023)

Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice‐based cohort study
por: Sato, Keiko, et al.
Publicado: (2016)

Herpes-Zoster-Associated Voiding Dysfunction in an Immunocompromised Patient
por: Alalwan, Adel A, et al.
Publicado: (2020)

The temporal impact of aging on the burden of herpes zoster
por: Varghese, Lijoy, et al.
Publicado: (2017)

Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review
por: Giannelos, Nikolaos, et al.
Publicado: (2023)

Herpes zoster segmental paresis in an immunocompromised breast cancer woman
por: Rastegar, Shirvan, et al.
Publicado: (2015)

Necrotizing Fasciitis Following Herpes Zoster Ophthalmicus in an Immunocompromised Patient
por: Cozzupoli, Grazia Maria, et al.
Publicado: (2019)

Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997–2006
por: Guignard, A. P., et al.
Publicado: (2014)

Meta-Regression of Herpes Zoster Incidence Worldwide
por: Curran, Desmond, et al.
Publicado: (2021)

Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
por: Mwakingwe-Omari, Agnes, et al.
Publicado: (2023)

914. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
por: Jain, Purva, et al.
Publicado: (2023)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Lifetime risk of herpes zoster in the population of Beijing, China
por: Lee, Christa, et al.
Publicado: (2023)

A systematic literature review of herpes zoster incidence worldwide
por: van Oorschot, Désirée, et al.
Publicado: (2021)

Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection
por: Amonchaisakda, Nuntouchaporn, et al.
Publicado: (2021)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series
por: Terheyden, Patrick, et al.
Publicado: (2023)

1440. Meta-regression Analysis of Worldwide Herpes Zoster Incidence
por: Yawn, Barbara P, et al.
Publicado: (2021)

Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study
por: Tanaka, Yoshiya, et al.
Publicado: (2018)

Herpes Zoster Induced Osteomyelitis in the Immunocompromised Patients: A 10-year Multicenter Study
por: Tabrizi, Reza, et al.
Publicado: (2014)

Post Herpes Zoster Trigeminal Trophic Syndrome in a Child: An Example of Immunocompromised District
por: Caccavale, Stefano, et al.
Publicado: (2016)

Herpes Zoster Induced Alveolar Bone Necrosis in Immunocompromised Patients; Two Case Reports
por: Gholami, Mahdi, et al.
Publicado: (2016)

A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children
por: Hwang, Ji Hyen, et al.
Publicado: (2019)

Herpes-zoster associated urinary retention in a 57-year-old immunocompromised male
por: Au, Vivienne H., et al.
Publicado: (2020)

1629. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review
por: Dooling, Kathleen L, et al.
Publicado: (2019)

Herpes Zoster Infection in an Immunocompromised Patient: A Case Report and Review of Corticosteroid’s Role
por: Seixas, Rui, et al.
Publicado: (2022)

Herpes zoster ophthalmicus or Herpes zoster maxillaris?
por: Chandravanshi, Shivcharan Lal, et al.
Publicado: (2009)

Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine
por: Curran, D, et al.
Publicado: (2022)

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
por: Curran, Desmond, et al.
Publicado: (2017)

Hospitalizations realted to herpes zoster infection in the Canary Islands, Spain (2005-2014)
por: García-Rojas, Amós, et al.
Publicado: (2017)

Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above
por: Curran, Desmond, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdnij3gv86tvdt6e8s4u0032oh